What's breaking now, across thousands of outlets.
In a study analyzing nearly 3,000 brain MRI exams, researchers found that living in highly disadvantaged neighborhoods was associated with adverse brain health. Results of the study were published in Radiology.
We haven't written up this one. Medical Xpress has the full story — the link below goes straight to it.
First teased in June and formally announced Tuesday as part of “Operation Trialblazer,” the program will partner drugmakers with research institutions to more quickly bring drugs into human testing.
Doctors have seen a 20 per cent rise in patients with asthma flare-ups, nose allergies and throat irritation.
The FDA is opening applications for a pilot program designed to shorten drug approval timelines and help the U.S. compete with countries like China and Australia.
Living in a disadvantaged neighbourhood may be linked to poorer brain health, with researchers finding higher brain age, lower total brain volume and more signs of vascular damage in people living in…
Experts warn that the new drug might be beckoning a new wave of the country’s opioid crisis.
It’s been a little more than a year since Omada Health went public, and the company reported its first profitable quarter this spring. Now, it's preparing for its first CEO transition.
